Odyssey Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-1.7M | $-842.3K | $-5.9M | $-8.4M | $-16.9M | $-4.3M | $-23.4M | $-483.1K |
| Depreciation & Amortization | — | $1.5K | $3.4K | $3.4K | $2.4K | $10.6K | $10.6K | $10.6K |
| Depreciation | — | — | $0 | $414 | $552 | $552 | $551 | $552 |
| Amortization | — | $1.5K | $3.4K | — | — | — | $40.8K | $10.0K |
| Stock-Based Compensation | $108.4K | $577.8K | $2.8M | — | — | $2.8M | $101.4K | $0 |
| Net Cash from Operating Activities | $-347.4K | $-1.2M | $-1.5M | $-1.5M | $-3.2M | $-649.1K | $-104.8K | $-146.1K |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $69.8K | $1.0M | $-10.1K | — | $0 | $0 | $0 | $0 |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $294.3K | $180.7K | $1.4M | $1.4M | $2.7M | $545.0K | $271.5K | $133.0K |
| Net Change in Cash | — | — | — | — | — | $-104.1K | $166.7K | $-13.0K |
| Free Cash Flow | — | — | — | — | — | — | — | — |